Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
2.695
-0.365 (-11.93%)
Jun 24, 2026, 11:27 AM EDT - Market open
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $7.73 million as of June 24, 2026. Its market cap has decreased by -73.80% in one year.
Market Cap
7.73M
Enterprise Value
6.47M
1-Year Change
-73.80%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $7.73M, a decrease of -86.71%. That is a compound annual growth rate of -44.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 7.73M | -51.24% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 11.52M |
| Kiora Pharmaceuticals | 11.21M |
| BioCardia | 11.00M |
| Chemomab Therapeutics | 10.94M |
| Intensity Therapeutics | 10.60M |
| BioRestorative Therapies | 10.44M |
| Jupiter Neurosciences | 10.33M |
| Quoin Pharmaceuticals | 9.34M |